Laboratory Testing for Menopause
Menopause should be diagnosed clinically based on age and menstrual history alone—no laboratory testing is needed for women ≥45 years with typical symptoms and amenorrhea ≥12 months. 1, 2, 3
When Laboratory Testing is NOT Indicated
For the typical clinical scenario, FSH testing is inappropriate and should be avoided 3:
- Women ≥45 years with 12 consecutive months of amenorrhea
- Women with typical vasomotor symptoms (hot flashes, night sweats) in the appropriate age range
- Women using oral contraceptives or hormonal IUDs (testing is neither recommended for diagnosis nor to decide when to stop contraception) 2
The diagnosis is purely clinical in these situations—no hormonal assays or imaging are indicated. 2
When Laboratory Testing MAY Be Helpful
Laboratory confirmation becomes useful only in specific circumstances where clinical diagnosis is uncertain 1, 4:
FSH and Estradiol Testing
When testing is warranted, measure both FSH and estradiol 1, 5:
- FSH >25 IU/L on two separate occasions at least 4 weeks apart 1
- Estradiol <20 pg/mL (or <50 pg/mL per some guidelines) 1, 5
- FSH:LH ratio >1 may provide additional confirmation 6
Specific Clinical Scenarios Requiring Testing:
1. Post-hysterectomy (ovaries intact) 4, 2:
- Replicate FSH measurements with estradiol levels
- FSH ≥40 IU/L combined with estradiol <20 pg/mL suggests menopause
- Measure at least 3 months post-procedure 2
2. Women <60 years needing confirmation for treatment decisions 5, 7:
- Prior to initiating aromatase inhibitors for breast cancer
- Luteinizing hormone, FSH, and estradiol all in postmenopausal range
- Must be measured before starting any systemic therapy 7
3. Premature ovarian insufficiency (age <40 years) 1:
- FSH >25 IU/L on two occasions >4 weeks apart
- Low estradiol
- AMH levels typically collapsed (though not required for diagnosis)
Critical Pitfalls to Avoid
Unreliable scenarios for FSH testing 5, 7, 2:
- During or after chemotherapy: Amenorrhea does not equal menopause; ovarian function may recover 8, 7
- While taking tamoxifen or toremifene: Hormone levels and menses are unreliable 5, 7
- On combined oral contraceptives or progestins: FSH will be artificially suppressed; must discontinue for ≥3 months before testing 1, 2
- Women using LH-RH agonists/antagonists: Cannot assign menopausal status 5
After gonadotoxic cancer treatment, the classic 12-month amenorrhea criterion cannot definitively diagnose menopause, and no examination can provide certainty 2. For breast cancer patients on hormonal contraception at diagnosis, default to considering them non-menopausal when choosing hormone therapy 2.
Anti-Müllerian Hormone (AMH)
AMH is not recommended for diagnosing menopause 9. While it correlates with ovarian reserve and may predict time to menopause, there are no validated diagnostic cutoffs, and it should not replace clinical assessment 8, 9.
Bottom line: In women ≥45 years with typical symptoms and amenorrhea, clinical diagnosis alone is sufficient and superior to laboratory testing, which adds no value and increases costs unnecessarily 2, 3.